Search Results 2291-2300 of 18232 for multiple%20sclerosis
... 20 mg daily of prednisone daily or equivalent). Prior exposure to ibrutinib or to a B-cell receptor (BCR) inhibitor (e.g., Bruton tyrosine kinase [Btk] ...
... 20 mg prednisone or equivalent for at least 4 weeks prior to screening are permitted;; Any rectal compounds;; Immunosuppresant therapy (azathioprine, 6 ...
Subject has DLCO of less than 20% of predicted. Subject has severe gas exchange abnormalities, PaCO2 of greater than 55mm Hg; PaO2 of less than 45 mm Hg on ...
Subject is taking >20 mg prednisone (or equivalent dose of a similar steroid) daily. Subject requires high level chronic immunomodulatory therapy to treat a ...
Patients with previously untreated primary AML who meet the customary criteria for AML with >= 20% bone marrow blasts as set out in the 2008 World Health ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
... two cycles of mosunetuzumab. An additional arm ... two cycles of mosunetuzumab administration ... CD20/CD3-directed bispecific antibodies; allogenic stem cell ...
Our lab has collaborated with researchers in neurology and neuroscience in more than 20 countries, along with colleagues at Mayo Clinic. These ...
Science Saturday: Scientists collaborate to paint a better picture of patient health. Dana Sparks. October 20, 2018. Research. What is the impact on health care ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!